Lanfermeijer M

No ORCID on file · 1 paper in corpus · active 2025
2025
Nature genetics ·doi:10.1038/s41588-025-02308-w

Mutagenic processes and clonal selection contribute to the development of therapy-associated secondary neoplasms, a known complication of cancer treatment. The association between tamoxifen therapy and secondary uterine cancers is uncommon …